A rhythm control treatment plan can also help the length of time a person’s heart is in atrial fibrillation. Antiarrhythmic drugs are the first choice in treating a-fib patients. Catheter ablation may be used in conjunction with antiarrhythmic drugs when these drugs prove not to work for the patient. Catheter ablation may be the cure for some atrial fibrillation patients. Cardioversion may be used before antiarrhythmic drugs are even started or catheter ablation is attempted. Anticoagulants must be used with cardioversion. Patients diagnosed with atrial fibrillation are usually prescribed anticoagulants, anyway, to prevent thrombi from forming. Catheter ablation and cardioversion procedures are invasive and pose the most risk to patients. The studies researched mostly used large sample sizes and patients 55 or older. The studies were able to be recreated and showed close to the same results. Santangeli and Lin isolated the pulmonary veins to recreate a study they researched before. Their study showed more places to get into the heart and different techniques to destroy the heart tissue. Antiarrhythmic drugs, catheter ablation, and cardioversion are the best choice for a rhythm control treatment plan of atrial fibrillation patients
A rhythm control treatment plan can also help the length of time a person’s heart is in atrial fibrillation. Antiarrhythmic drugs are the first choice in treating a-fib patients. Catheter ablation may be used in conjunction with antiarrhythmic drugs when these drugs prove not to work for the patient. Catheter ablation may be the cure for some atrial fibrillation patients. Cardioversion may be used before antiarrhythmic drugs are even started or catheter ablation is attempted. Anticoagulants must be used with cardioversion. Patients diagnosed with atrial fibrillation are usually prescribed anticoagulants, anyway, to prevent thrombi from forming. Catheter ablation and cardioversion procedures are invasive and pose the most risk to patients. The studies researched mostly used large sample sizes and patients 55 or older. The studies were able to be recreated and showed close to the same results. Santangeli and Lin isolated the pulmonary veins to recreate a study they researched before. Their study showed more places to get into the heart and different techniques to destroy the heart tissue. Antiarrhythmic drugs, catheter ablation, and cardioversion are the best choice for a rhythm control treatment plan of atrial fibrillation patients